Neurocompute Narrative Velocity Map
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative
Velocity Map

Explore the Parkinson’s research intelligence diagram before entering the Neurocompute platform.

NC
Neurocompute
AI Parkinson’s Intelligence Terminal
RESEARCH PAPER

HTRA1 and brain disorders: A balancing act across neurodegeneration and repair.

PMID
41932381
Journal
Progress in neurobiology
Publication Date
2026-04-01
Grade
C

AI Summary

This review synthesizes evidence that the serine protease HTRA1 regulates brain proteostasis, ECM remodeling, and signaling (TGF-β, Wnt, Notch), has both protective and pathogenic roles, interacts with ApoE and tau, and presents biomarker and therapeutic targeting opportunities, with relevance…

Why It Matters

HTRA1 influences proteostasis, inflammation, and vascular/ECM integrity—mechanisms relevant to Parkinson’s pathobiology and drug targeting—so the review highlights a moderately actionable target space (including inhibitors and biomarkers), but it lacks direct, PD-specific links to core processes…

Abstract

High temperature requirement protein A1 (HTRA1) is a trypsin-like serine protease increasingly recognized as a central regulator of brain homeostasis. HTRA1 is broadly expressed in the brain, where it regulates proteostasis, extracellular matrix (ECM) remodeling, and important signaling pathways such as TGF-β, Wnt, and Notch. These functions are essential for maintaining blood-brain barrier integrity, supporting tissue repair, and restraining inflammation. HTRA1 is a double-edged sword, as both insufficient and excessive activity can lead to neurodegenerative and vascular pathology. Reduced HTRA1 levels are linked to ECM accumulation and vascular fibrosis, while elevated activity contributes to tissue breakdown, inflammation, and impaired repair. This dual role is implicated in a range of disorders, including cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy, small vessel disease, age-related macular degeneration, Alzheimer's disease, Parkinson's disease, and multiple sclerosis. We review recent insights into HTRA1's interactions with ApoE and tau, its roles in lipid and cytoskeletal regulation, and its modulation by inhibitors such as Macrophage Migration Inhibitory Factor. Finally, we explore its biomarker potential and therapeutic targeting strategies. Understanding the mechanisms behind HTRA1's shift from protective to pathological is crucial for developing targeted therapies that preserve its beneficial roles.

Score Breakdown

AI Score
65.0
Base Score
63.9
Rank Score
61.8
Narrative Velocity
-
AI Confidence
-
Neurocompute Parkinson’s Narrative Velocity Infographic
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative Velocity Map

Explore the full Parkinson’s research intelligence diagram.

Expand Intelligence View →
Full Neurocompute Infographic
Full Neurocompute Infographic